Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for BSX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 16.63%
March 31, 2026 25.74%
December 31, 2025 12.68%
September 30, 2025 14.91%
June 30, 2025 15.71%
March 31, 2025 14.41%
December 31, 2024 12.32%
September 30, 2024 11.12%
June 30, 2024 7.82%
March 31, 2024 12.79%
December 31, 2023 13.53%
September 30, 2023 14.29%
June 30, 2023 7.50%
March 31, 2023 9.27%
December 31, 2022 4.32%
September 30, 2022 5.93%
June 30, 2022 8.01%
March 31, 2022 3.67%
December 31, 2021 3.01%
September 30, 2021 14.29%
June 30, 2021 6.04%
March 31, 2021 12.39%
December 31, 2020 5.61%
September 30, 2020 -5.83%
June 30, 2020 -7.34%
Date Value
March 31, 2020 0.43%
December 31, 2019
September 30, 2019 4.65%
June 30, 2019 5.85%
March 31, 2019 17.01%
December 31, 2018 15.07%
September 30, 2018 18.05%
June 30, 2018 22.29%
March 31, 2018 12.53%
December 31, 2017 -25.54%
September 30, 2017 12.74%
June 30, 2017 6.47%
March 31, 2017 13.43%
December 31, 2016 5.66%
September 30, 2016 10.83%
June 30, 2016 -9.74%
March 31, 2016 10.29%
December 31, 2015 -7.18%
September 30, 2015 -10.49%
June 30, 2015 5.53%
March 31, 2015 -0.06%
December 31, 2014 -15.85%
September 30, 2014 2.33%
June 30, 2014 0.21%
March 31, 2014 7.50%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.37%
Becton, Dickinson & Co. 9.05%
Penumbra, Inc. 8.92%
Insulet Corp. 11.85%
Intuitive Surgical, Inc. 28.46%